stanozolol has been researched along with Arterial Occlusive Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duckert, F; Lämmle, B; Noll, G | 1 |
| Barrie, WW | 1 |
| Chakrabarti, R | 1 |
3 other study(ies) available for stanozolol and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Treatment with stanozolol before thrombolysis in patients with arterial occlusions.
Topics: Aged; alpha-2-Antiplasmin; Arterial Occlusive Diseases; Fibrinolysis; Fibrinolytic Agents; Humans; Middle Aged; Plasminogen; Premedication; Stanozolol | 1985 |
Deficient fibrinolysis associated with rapidly progressive arterial disease.
Topics: Adult; Anticoagulants; Aortography; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Electrocardiography; Femoral Artery; Fibrinolysis; Foot; Humans; Iliac Artery; Intermittent Claudication; Liver; Male; Polyethylene Terephthalates; Popliteal Artery; Pulse; Stanozolol; Sympathectomy; Thrombosis; Toes | 1974 |
Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
Topics: Administration, Oral; Arterial Occlusive Diseases; Cholesterol; Drug Therapy, Combination; Ethylestrenol; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glass; Humans; Metformin; Methods; Phenformin; Platelet Adhesiveness; Stanozolol; Time Factors | 1972 |